These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A clinical review of echinocandins in pediatric patients. VandenBussche HL; Van Loo DA Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006 [TBL] [Abstract][Full Text] [Related]
4. Echinocandins: production and applications. Emri T; Majoros L; Tóth V; Pócsi I Appl Microbiol Biotechnol; 2013 Apr; 97(8):3267-84. PubMed ID: 23463246 [TBL] [Abstract][Full Text] [Related]
5. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related]
6. The echinocandins. Cappelletty D; Eiselstein-McKitrick K Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149 [TBL] [Abstract][Full Text] [Related]
7. Recent approaches to antifungal therapy for invasive mycoses. Mathew BP; Nath M ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067 [TBL] [Abstract][Full Text] [Related]
8. Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces. Katragkou A; Roilides E; Walsh TJ Clin Infect Dis; 2015 Dec; 61 Suppl 6():S622-9. PubMed ID: 26567280 [TBL] [Abstract][Full Text] [Related]
10. Micafungin: a sulfated echinocandin. Hashimoto S J Antibiot (Tokyo); 2009 Jan; 62(1):27-35. PubMed ID: 19132058 [TBL] [Abstract][Full Text] [Related]
11. Echinocandins--new antifungal agents. Stan CD; Tuchiluş C; Stan CI Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):528-36. PubMed ID: 25076727 [TBL] [Abstract][Full Text] [Related]
12. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Fera MT; La Camera E; De Sarro A Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707 [TBL] [Abstract][Full Text] [Related]
13. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia. Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191 [TBL] [Abstract][Full Text] [Related]
14. Anidulafungin, a new echinocandin: in vitro activity. Morace G; Borghi E; Iatta R; Montagna MT Drugs; 2009; 69 Suppl 1():91-4. PubMed ID: 19877740 [TBL] [Abstract][Full Text] [Related]
16. Echinocandin antifungals: review and update. Morrison VA Expert Rev Anti Infect Ther; 2006 Apr; 4(2):325-42. PubMed ID: 16597212 [TBL] [Abstract][Full Text] [Related]
17. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology and antifungal properties of anidulafungin, a new echinocandin. Estes KE; Penzak SR; Calis KA; Walsh TJ Pharmacotherapy; 2009 Jan; 29(1):17-30. PubMed ID: 19113794 [TBL] [Abstract][Full Text] [Related]
19. Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods. Cantón E; Pemán J; Hervás D; Espinel-Ingroff A J Antimicrob Chemother; 2013 Apr; 68(4):864-8. PubMed ID: 23228935 [TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Delattin N; Cammue BP; Thevissen K Future Med Chem; 2014 Jan; 6(1):77-90. PubMed ID: 24358949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]